These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
242 related articles for article (PubMed ID: 28598238)
1. NLRC3 regulates cellular proliferation and apoptosis to attenuate the development of colorectal cancer. Karki R; Malireddi RKS; Zhu Q; Kanneganti TD Cell Cycle; 2017 Jul; 16(13):1243-1251. PubMed ID: 28598238 [TBL] [Abstract][Full Text] [Related]
2. NLRC3 is an inhibitory sensor of PI3K-mTOR pathways in cancer. Karki R; Man SM; Malireddi RKS; Kesavardhana S; Zhu Q; Burton AR; Sharma BR; Qi X; Pelletier S; Vogel P; Rosenstiel P; Kanneganti TD Nature; 2016 Dec; 540(7634):583-587. PubMed ID: 27951586 [TBL] [Abstract][Full Text] [Related]
3. IMPDH2 promotes colorectal cancer progression through activation of the PI3K/AKT/mTOR and PI3K/AKT/FOXO1 signaling pathways. Duan S; Huang W; Liu X; Liu X; Chen N; Xu Q; Hu Y; Song W; Zhou J J Exp Clin Cancer Res; 2018 Dec; 37(1):304. PubMed ID: 30518405 [TBL] [Abstract][Full Text] [Related]
4. NLRC3 inhibits PDGF-induced PASMCs proliferation via PI3K-mTOR pathway. Zha LH; Zhou J; Tan Y; Guo S; Zhang MQ; Li S; Yan P; Yu ZX J Cell Physiol; 2020 Dec; 235(12):9557-9567. PubMed ID: 32383265 [TBL] [Abstract][Full Text] [Related]
5. FoxO proteins' nuclear retention and BH3-only protein Bim induction evoke mitochondrial dysfunction-mediated apoptosis in berberine-treated HepG2 cells. Shukla S; Rizvi F; Raisuddin S; Kakkar P Free Radic Biol Med; 2014 Nov; 76():185-99. PubMed ID: 25128467 [TBL] [Abstract][Full Text] [Related]
6. Dihydromethysticin, a natural molecule from Kava, suppresses the growth of colorectal cancer via the NLRC3/PI3K pathway. Pan H; Liu F; Wang J; Zhao M; Wang D; Jia C; Wang T; Chen Z; Fan Y; Liang D; Meng Q Mol Carcinog; 2020 Jun; 59(6):575-589. PubMed ID: 32187756 [TBL] [Abstract][Full Text] [Related]
7. Exclusive inhibition of PI3K/Akt/mTOR signaling is not sufficient to prevent PDGF-mediated effects on glycolysis and proliferation in colorectal cancer. Moench R; Grimmig T; Kannen V; Tripathi S; Faber M; Moll EM; Chandraker A; Lissner R; Germer CT; Waaga-Gasser AM; Gasser M Oncotarget; 2016 Oct; 7(42):68749-68767. PubMed ID: 27626684 [TBL] [Abstract][Full Text] [Related]
8. The high protein expression of FOXO3, but not that of FOXO1, is associated with markers of good prognosis. Lallemand F; Vacher S; de Koning L; Petitalot A; Briaux A; Driouch K; Callens C; Schnitzler A; Lecerf C; Oulie-Bard F; Barbet A; Vincent A; Zinn-Justin S; Lopez BS; Lidereau R; Bieche I; Caputo SM Sci Rep; 2020 Apr; 10(1):6920. PubMed ID: 32332845 [TBL] [Abstract][Full Text] [Related]
9. The Green Walnut Husks Induces Apoptosis of Colorectal Cancer through Regulating NLRC3/PI3K Pathway. Chen C; An N; Pang D; Cheng Y; Chen Y; Feng X; Lei H; He W; Yang B; Zhang Y; Zhao X Curr Pharm Des; 2023; 29(12):940-946. PubMed ID: 37005539 [TBL] [Abstract][Full Text] [Related]
10. Angiogenin interacts with ribonuclease inhibitor regulating PI3K/AKT/mTOR signaling pathway in bladder cancer cells. Peng Y; Li L; Huang M; Duan C; Zhang L; Chen J Cell Signal; 2014 Dec; 26(12):2782-92. PubMed ID: 25193113 [TBL] [Abstract][Full Text] [Related]
11. Deptor Is a Novel Target of Wnt/β-Catenin/c-Myc and Contributes to Colorectal Cancer Cell Growth. Wang Q; Zhou Y; Rychahou P; Harris JW; Zaytseva YY; Liu J; Wang C; Weiss HL; Liu C; Lee EY; Evers BM Cancer Res; 2018 Jun; 78(12):3163-3175. PubMed ID: 29666061 [TBL] [Abstract][Full Text] [Related]
12. F-box and leucine-rich repeat protein 5 promotes colon cancer progression by modulating PTEN/PI3K/AKT signaling pathway. Yao H; Su S; Xia D; Wang M; Li Z; Chen W; Ren L; Xu L Biomed Pharmacother; 2018 Nov; 107():1712-1719. PubMed ID: 30257389 [TBL] [Abstract][Full Text] [Related]
13. Growth Factors, PI3K/AKT/mTOR and MAPK Signaling Pathways in Colorectal Cancer Pathogenesis: Where Are We Now? Stefani C; Miricescu D; Stanescu-Spinu II; Nica RI; Greabu M; Totan AR; Jinga M Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638601 [TBL] [Abstract][Full Text] [Related]
14. Negative regulation of PI3K/AKT/mTOR axis regulates fibroblast proliferation, apoptosis and autophagy play a vital role in triptolide-induced epidural fibrosis reduction. Dai J; Sun Y; Chen D; Zhang Y; Yan L; Li X; Wang J Eur J Pharmacol; 2019 Dec; 864():172724. PubMed ID: 31600493 [TBL] [Abstract][Full Text] [Related]
15. Deoxyshikonin isolated from Zhu Y; Zhong Y; Long X; Zhu Z; Zhou Y; Ye H; Zeng X; Zheng X Pharm Biol; 2019 Dec; 57(1):412-423. PubMed ID: 31230505 [No Abstract] [Full Text] [Related]
16. GPCR48/LGR4 promotes tumorigenesis of prostate cancer via PI3K/Akt signaling pathway. Liang F; Yue J; Wang J; Zhang L; Fan R; Zhang H; Zhang Q Med Oncol; 2015 Mar; 32(3):49. PubMed ID: 25636507 [TBL] [Abstract][Full Text] [Related]
17. Non-immunosuppressive triazole-based small molecule induces anticancer activity against human hormone-refractory prostate cancers: the role in inhibition of PI3K/AKT/mTOR and c-Myc signaling pathways. Leu WJ; Swain ShP; Chan SH; Hsu JL; Liu SP; Chan ML; Yu CC; Hsu LC; Chou YL; Chang WL; Hou DR; Guh JH Oncotarget; 2016 Nov; 7(47):76995-77009. PubMed ID: 27769069 [TBL] [Abstract][Full Text] [Related]
18. Loss of fatty acid synthase suppresses the malignant phenotype of colorectal cancer cells by down-regulating energy metabolism and mTOR signaling pathway. Chang L; Wu P; Senthilkumar R; Tian X; Liu H; Shen X; Tao Z; Huang P J Cancer Res Clin Oncol; 2016 Jan; 142(1):59-72. PubMed ID: 26109148 [TBL] [Abstract][Full Text] [Related]
19. Concomitant reduction of c-Myc expression and PI3K/AKT/mTOR signaling by quercetin induces a strong cytotoxic effect against Burkitt's lymphoma. Granato M; Rizzello C; Romeo MA; Yadav S; Santarelli R; D'Orazi G; Faggioni A; Cirone M Int J Biochem Cell Biol; 2016 Oct; 79():393-400. PubMed ID: 27620077 [TBL] [Abstract][Full Text] [Related]
20. FoxO3a functions as a key integrator of cellular signals that control glioblastoma stem-like cell differentiation and tumorigenicity. Sunayama J; Sato A; Matsuda K; Tachibana K; Watanabe E; Seino S; Suzuki K; Narita Y; Shibui S; Sakurada K; Kayama T; Tomiyama A; Kitanaka C Stem Cells; 2011 Sep; 29(9):1327-37. PubMed ID: 21793107 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]